US Health Secretary Explores SSRI Ban

U.S. Health Secretary Robert F. Kennedy Jr. and officials from the United States — United States Department of Health and Human Services explored the possibility of banning certain Selective serotonin reuptake inhibitor (SSRI) antidepressants, including Sertraline, Fluoxetine, and Escitalopram. This comes as Robert F. Kennedy Jr. rolled out initiatives to reduce SSRI use, such as reimbursement guidelines for physicians and investment in healthcare provider training. The United States — United States Department of Health and Human Services, however, denied any discussions about banning SSRIs. Robert F. Kennedy Jr. has previously made unsubstantiated claims linking SSRIs to violence and fetal risks. The American Psychological Association considers SSRIs an evidence-based treatment and objects to the 'overmedicalization' framing of the mental health crisis. Experts note that the United States — Food and Drug Administration lacks the authority to unilaterally ban already-approved medications without new scientific evidence of risk or proof of false statements in original applications, as demonstrated by Amgen's refusal to withdraw its drug Avacopan.